Ping An Biomedical Co., Ltd. (PASW)

NASDAQ: PASW · Real-Time Price · USD

0.1383

+0.0037 (2.75%)

At close: Sep 18, 2026, 4:00 PM EDT

0.1330

-0.0053 (-3.83%)

After-hours: Sep 18, 2026, 6:01 PM EDT

Ping An Biomedical Income Statement

Financials in millions CNY. Fiscal year is October - September.

Millions CNY. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	25.51	34.15	87.62	82.56	114.55	99.52
Revenue Growth	-57.57%	-61.03%	6.13%	-27.92%	15.10%	79.43%
Cost of Revenue	23.15	33.2	82.21	78.32	100.4	85.25
Gross Profit	2.37	0.95	5.42	4.24	14.14	14.27
Selling, General & Admin	9.78	6.31	5.3	3.6	3.52	3.76
Operating Expenses	12.91	15.65	5.42	3.63	3.33	6
Operating Income	-10.55	-14.7	-0	0.61	10.82	8.27
Interest Expense	-0.29	-0.31	-0.71	-1.74	-1.57	-1.36
Interest & Investment Income	0.39	0.33	0	0.16	0.04	0
Currency Exchange Gain (Loss)	-	-	-0.01	-	-0	0.19
Other Non Operating Income (Expenses)	0.1	-0	0.03	1.01	0.34	0.72
Pretax Income	-4.66	-14.68	-0.68	0.04	9.63	7.82
Income Tax Expense	-0.89	-1.86	0.6	1.04	2.4	2.61
Net Income	-3.77	-12.83	-1.28	-0.99	7.23	5.21
Net Income to Common	-3.77	-12.83	-1.28	-0.99	7.23	5.21
Net Income Growth	-	-	-	-	38.61%	170.96%
Shares Outstanding (Basic)	35	18	18	18	18	18
Shares Outstanding (Diluted)	35	18	18	18	18	18
Shares Change	93.03%	2.66%	-	-	-	-
EPS (Basic)	-0.11	-0.69	-0.07	-0.06	0.40	0.29
EPS (Diluted)	-0.11	-0.69	-0.07	-0.06	0.40	0.29
EPS Growth	-	-	-	-	38.61%	170.96%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Free Cash Flow	-5.54	-6.43	14.63	-6.08	21.06	-31.4
Free Cash Flow Per Share	-0.16	-0.35	0.81	-0.34	1.17	-1.74
Gross Margin	9.27%	2.78%	6.18%	5.14%	12.35%	14.34%
Operating Margin	-41.34%	-43.05%	-0.00%	0.74%	9.44%	8.31%
Profit Margin	-14.78%	-37.57%	-1.47%	-1.20%	6.31%	5.24%
Free Cash Flow Margin	-21.73%	-18.82%	16.70%	-7.37%	18.39%	-31.55%
EBITDA	-10.54	-14.7	0.01	0.65	10.84	8.29
EBITDA Margin	-41.32%	-43.04%	0.01%	0.78%	9.46%	8.33%
D&A For EBITDA	0	0.01	0.01	0.03	0.02	0.02
EBIT	-10.55	-14.7	-0	0.61	10.82	8.27
EBIT Margin	-41.34%	-43.05%	-0.00%	0.74%	9.44%	8.31%
Effective Tax Rate	-	-	-	2484.34%	24.92%	33.32%